MRKR / Marker Therapeutics, Inc. - Net Long/Short Value

마커 테라퓨틱스(Marker Therapeutics), Inc.
US ˙ NasdaqCM ˙ US57055L2060

MRKR / Marker Therapeutics, Inc. - Net Long/Short Value
이 페이지에는 13F 또는 NPORT 보고서(Filling)에 보고된 각 기관들의 보유 주식에 대한 "순 롱/숏 평가"(Net long/short valuation) 지표가 게시됩니다. Fintel은 순 롱/숏 가치(Net long/short value)을 계산하기 위해, 콜옵션 가치에 주식 가치를 더하고, 풋옵션 가치를 뺍니다. 공매도 포지션을 보고하는 펀드들은 주식 값을 음수(-)로 보고합니다. 순 롱 포지션은 순 롱/숏 열에 양수(+)를 표시되며, 순 숏 포지션(매도 포지션)은 해당 열에 음수로 표시됩니다.
주주 지분 가치
($1,000)
콜 가치
($1,000)
풋 가치
($1,000)
순 롱/숏
($1,000)
Vanguard Group Inc
Invst, LLC
Group One Trading, L.p.
Blue Owl Capital Holdings LP
Susquehanna International Group, Llp
Vanguard Fiduciary Trust Co
SBI Securities Co., Ltd.
Aisling Capital Management LP
Jane Street Group, Llc
XTX Topco Ltd
Two Sigma Investments, Lp
Signaturefd, Llc
Wells Fargo & Company/mn
Caitong International Asset Management Co., Ltd
Creative Planning
Ashton Thomas Private Wealth, LLC
Vanguard Global Advisers, LLC
UBS Group AG
Matrix Asset Advisors Inc/ny
Jpmorgan Chase & Co
Geode Capital Management, Llc
LPL Financial LLC
State Street Corp
Bnp Paribas Arbitrage, Sa
Northern Trust Corp
Hrt Financial Lp
Two Sigma Securities, Llc
Hilltop National Bank
Tower Research Capital LLC (TRC)
Advisor Group Holdings, Inc.
Vanguard Capital Management Llc
Morgan Stanley
Fifth Third Bancorp
Renaissance Technologies Llc
International Assets Investment Management, Llc
Western Wealth Management, LLC
NEA Management Company, LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:GX1 €1.20
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista